Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism

Area of Science:

• Endocrinology
• Molecular Biology
• Biomarker Discovery

Background:

• Primary aldosteronism (PA) is a prevalent, treatable endocrine disorder often underdiagnosed due to complex diagnostics.
• Underdiagnosis of PA contributes significantly to cardiovascular morbidity and mortality.
• A simplified diagnostic approach is needed to improve patient outcomes.

Purpose of the Study:

• To review the potential of circulating microRNAs (miRNAs) as biomarkers for primary aldosteronism.
• To discuss the challenges in identifying reproducible circulating miRNA biomarkers.
• To present strategies for overcoming these challenges, exemplified by the ENS@T-HT study.

Main Methods:

• Review of existing literature on microRNA expression in primary aldosteronism.
• Analysis of technical challenges impacting the reproducibility of circulating miRNA biomarker studies.
• Description of the ongoing ENS@T-HT study's approach to identifying circulating miRNA biomarkers for PA.

Main Results:

• Evidence suggests circulating miRNAs are altered in primary aldosteronism and could serve as diagnostic biomarkers.
• Significant technical and reproducibility challenges exist in identifying reliable circulating miRNA biomarkers.
• The ENS@T-HT study is designed to address these challenges through a robust methodology.

Conclusions:

• Circulating miRNAs hold promise as accessible biomarkers for primary aldosteronism, potentially simplifying diagnosis.
• Overcoming reproducibility issues is critical for the clinical utility of miRNA-based diagnostics.
• Methodological rigor, as employed in studies like ENS@T-HT, is essential for validating these biomarkers.